HAG
GILD icon

HF Advisory Group’s Gilead Sciences GILD Stock Holding History

HF Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
23,463
+2,544
+12% +$335K 0.92% 41
2026
Q1 		$2.92M Buy
20,919
+343
+2% +$48K 0.99% 35
2025
Q4 		$2.53M Buy
20,576
+712
+4% +$86.5K 0.88% 39
2025
Q3 		$2.2M Buy
19,864
+1,344
+7% +$153K 0.81% 46
2025
Q2 		$2.05M Buy
18,520
+1,580
+9% +$168K 0.81% 44
2025
Q1 		$1.9M Buy
16,940
+764
+5% +$78.8K 0.83% 40
2024
Q4 		$1.49M Sell
16,176
-1,737
-10% -$156K 0.69% 55
2024
Q3 		$1.5M Sell
17,913
-277
-2% -$21.1K 0.7% 52
2024
Q2 		$1.25M Buy
18,190
+2,724
+18% +$182K 0.65% 57
2024
Q1 		$1.13M Buy
15,466
+639
+4% +$49.1K 0.63% 60
2023
Q4 		$1.2M Buy
14,827
+308
+2% +$24K 0.77% 46
2023
Q3 		$1.09M Buy
14,519
+1,769
+14% +$136K 0.81% 46
2023
Q2 		$983K Buy
12,750
+2,219
+21% +$177K 0.78% 47
2023
Q1 		$874K Buy
10,531
+1,626
+18% +$135K 0.78% 46
2022
Q4 		$764K Buy
+8,905
New +$705K 0.77% 49

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

HF Advisory Group's GILD Position: Q2 2026 in Review

HF Advisory Group increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $335K and bringing the position to 23,463 shares worth $2.96M. The position accounts for 0.92% of the portfolio, ranked #41.

HF Advisory Group first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HF Advisory Group held 23,463 shares of Gilead Sciences worth $2.96M as of Q2 2026.
  • HF Advisory Group bought 2,544 Gilead Sciences shares in Q2 2026, an estimated $335K.
  • Gilead Sciences made up 0.92% of HF Advisory Group's portfolio in Q2 2026, its #41 holding.
  • HF Advisory Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.